2017 Agenda

Session times are subject to change. 

Mon, 11/13

5:00 PM – 7:00 PM
6:00 PM – 7:30 PM
Film screening: The Gene Doctors Join fellow Partnering for Cures attendees in viewing the new documentary The Gene Doctors. Every year more than 1 million babies are born with a disease caused by a single error in one of our many genes.

Tue, 11/14

7:30 AM – 5:00 PM
Partnering The partnering app, P4C Connect, allows participants to connect with each other to help advance their research and development goals. Partnering happens throughout the meeting, in addition to designated partnering breaks in between program elements.
7:30 AM – 3:30 PM
8:00 AM – 9:00 AM
Breakfast Roundtable Discusssions Kick off Partnering for Cures with an opportunity to network with peers who share your goals and interests. These roundtables bring together meeting participants across disciplines and sectors to discuss specific topics in biomedical R&D.
9:00 AM – 9:15 AM
Introductory Remarks
Welcoming Remarks
9:15 AM – 9:30 AM
Time=Lives Talk: When the Personal and Professional Collide When biomedical researchers like Reg Kelly confront a major disease such as dementia in their personal lives, they quickly recognize that effective cures for their loved ones require collaboration across conventional fields such as immunology, neurology, and stem cell biology.
  • Regis Kelly
    Director, QB3; Byers Family Distinguished Professor, University of California, San Francisco
9:30 AM – 10:30 AM
PLENARY: "Recommended for You:" Can Direct-to-Consumer Expertise Inform Precision Medicine? Most of us appreciate the way the predictive analytics employed by companies like Amazon and Netflix seem to anticipate our needs and match us to the right solutions. Where are we in the quest to use that power in the service of developing personalized models for treating and curing disease?...

  • Silas Buchanan
    Co-Founder and CEO, Institute for eHealth Equity
  • Eric Dishman
    Director, Precision Medicine Initiative Cohort Program, National Institutes of Health
  • Kathy Giusti
    Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator
  • Christine Lemke
    Co-Founder and President, Evidation Health
10:30 AM – 11:00 AM
11:00 AM – 12:00 PM
BREAKOUT SESSION: Medicine Needs Data Scientists Massive volumes of data are generated as part of biomedical research and everyday clinical care. While data have always driven biomedical innovation, the development of the internet and big data tools provide new opportunities to collaborate, analyze, and accelerate progress.

  • Nate Crisel
    Vice President and Head, Real World Informatics and Analytics, Astellas
  • Martin Entwistle
    President and CEO, Ares Health Systems
  • Magali Haas
    CEO and President, Cohen Veterans Bioscience
  • Guneet Walia
    Senior Director, Research and Medical Affairs, Bonnie J. Addario Lung Cancer Foundation
BREAKOUT SESSION: Putting Patients at the Center of the Value Conversation Value in health care can mean different things to different stakeholders. Payer priorities may not match up with those of manufacturers, and both may assess value entirely differently than public health entities. However, no matter which of these stakeholders is measuring value, it’s important that value assessments always robustly consider...
  • Sara Radcliffe
    President and Chief Executive Officer, California Life Sciences Association

  • Andy Baskin
    National Medical Director, Quality and Provider Performance Measurement, Aetna
  • Nancy McGee
    Executive Vice President, Avalere Health
  • Amy O'Sullivan
    Senior Director and Head, Health Economics and Outcomes Research, Alkermes
  • Michael Siegel
    Vice President, Research Programs, National Psoriasis Foundation
12:15 PM – 12:45 PM
12:45 PM – 1:45 PM
PLENARY: Artificial Intelligence and Machine Learning in Medical R&D: Hope or Hype? Applications of artificial intelligence and machine learning to health care and research have been exploding over the last year – and sometimes blowing up as we climb the learning curve. There is great hope, however, that these technologies will reduce drug discovery times and be the ultimate enabler of precision medicine.
  • Atul Butte
    Director, Institute for Computational Health Sciences, and Priscilla Chan and Mark Zuckerberg Distinguished Professor, University of California, San Francisco

  • John Baldoni
    Senior Vice President, DPU Head, ln Silico Discovery, GSK Pharmaceuticals
  • Iya Khalil
    Co-Founder and Chief Commercial Officer, GNS Healthcare
  • Alice Zhang
    CEO and Co-founder, Verge Genomics
1:45 PM – 2:15 PM
2:15 PM – 3:15 PM
BREAKOUT SESSION: Health Citizenship: Creating a New Social Compact for Health Our health is both an individual and a collective responsibility as we all bear the costs of disease and reap the benefits of healthier communities. Technology has provided new tools to enable people to easily access their health data and understand their health status, and the federal government has declared...

BREAKOUT SESSION: Tech Culture Meets Medical Research Culture Many of the behaviors slowing progress in the discovery and development of new medical products are challenges that organizations everywhere have been confronting for decades, if not centuries: lack of effective communication and collaboration, silo-ization of information and expertise, incentives not aligned with the collective behaviors we want to see.

  • Jeff Conklin
    Senior Vice President, Business Insights and Analytics, Bristol-Myers Squibb
  • Riley Ennis
    Co-Founder and Chief Operating Officer, Freenome
  • Eri Gentry
    Co-founder, BioCurious; Science and Technology Researcher, Institute for the Future
  • Lisa Suennen
    Senior Managing Director, Healthcare Investing, GE Ventures; Managing Partner, Venture Valkyrie, LLC
  • Matt Wilsey
    Chairman, President, and Co-founder, Grace Science Foundation
3:15 PM – 4:00 PM
P4C Unplugged with Mike Milken Join Mike Milken and special guests for a discussion on the future of medical research and innovation.

4:00 PM – 5:00 PM
PLENARY: A New Generation of Philanthropy Joins the Battle Against Disease Following in Bill Gates’ footsteps is a new generation of entrepreneurs who are pledging significant portions of their philanthropy to solving humankind’s most pressing health challenges. Along with their funding, they are bringing new models of philanthropy as well as expectations that the medical research ecosystem is having to adapt to.